Results 31 to 40 of about 2,406 (151)

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance [PDF]

, 2004
Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are mainstays of PCP treatment and prophylaxis.
Meja Rabodonirina, Chiara Atzori, Benfield, T, Helweg-Larsen, J, Rabodonirina, Meja, Robert Miller, Crothers, KA, Thomas Benfield, Huang, Laurence, Atzori, C, Rabodonirina, M, Laurence Huang, Kristina Crothers, Miller, R, Haung, L, Helweg-Larsen, Jannik, Jannik Helweg-Larsen, Miller, Robert, Crothers, Kristina, Benfield, Thomas, Atzori, Chiara   +20 more
core   +1 more source

Burden, mortality, and associated factors of Pneumocystis jerovesi pneumonia among human immunodeficiency virus/AIDS patients: Systematic review and meta-analysis

Indian Journal of Health Sciences and Biomedical Research KLEU, 2021
Pneumocystis pneumonia has classically been described as a serious complication in human immunodeficiency virus (HIV) infected patients caused by Pneumocystis Jirovecii pneumonia formerly called Pneumocystis Carinii Pneumonia (PJP).
Ephrem Awulachew, Kuma Diriba, Asrat Anja, Feven Wudneh, Aschalew Gemede   +4 more
doaj   +1 more source

Increasing Pneumocystis pneumonia, England, UK, 2000-2010. [PDF]

, 2013
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000-2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Nichols, Gordon, Katherine L. Henderson, Nick Phin, Maini, Rishma, Delpech, Valerie, Gordon Nichols, Valerie Delpech, Rishma Maini, Phin, Nick, Theresa Lamagni, Henderson, Katherine L, Elizabeth A. Sheridan, Lamagni, Theresa, Sheridan, Elizabeth A   +13 more
core   +1 more source

Comment on “Pneumocystis jirovecii Pneumonia in a HIV‐Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis”

, 2023
Case Reports in Infectious Diseases, Volume 2023, Issue 1, 2023.
Gilles Nevez, Claire Hoffmann, Solène Le Gal, Anna Skiada   +3 more
wiley   +1 more source

Concurrent COVID-19 and pneumocystis carinii pneumonia in a patient subsequently found to have underlying hairy cell leukemia

Radiology Case Reports, 2022
SARS-CoV-2 infection manifestation has great diversity and it becomes even greater while co-infection occurs or there is a serious underlying disease in an affected patient.
Vahan Moradians, MD, Bahareh Shateri Amiri, MD, Leyla Bahadorizadeh, MD, Milad Gholizadeh Mesgarha, MD, Shahrzad Sadeghi, MD   +4 more
doaj   +1 more source

Pneumocystis jirovecii Pneumonia: A Revisit to the Old Malady [PDF]

Journal of Clinical and Diagnostic Research, 2019
Pneumocystis jirovecii Pneumonia (PJP) was previously called as Pneumocystis carinii Pneumonia (PCP), it is one of the most common opportunistic fungal infection in immuno-compromised individuals. Patients may present clinical symptoms such as fever, non-
Kante Meenakshi, Racherla Rishi Gowtham, Kalawat Usha   +2 more
doaj   +1 more source

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients

Avicenna Journal of Medicine, 2023
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T. Zangeneh, Ahmad Iftikhar   +9 more
doaj   +1 more source

Evaluation of a commercial Loop‐mediated Isothermal Amplification (LAMP) assay for rapid detection of Pneumocystis jirovecii

Mycoses, Volume 63, Issue 10, Page 1107-1114, October 2020., 2020
Summary Background Various tools are obtainable for the detection of Pneumocystis jirovecii, among them qPCR promising highest sensitivity. A novel molecular method is commercially available, the loop‐mediated isothermal amplification (LAMP) assay. Objectives We compared the performance of the LAMP eazyplex® Pneumocystis jirovecii with the RealStar ...
Ulrike Scharmann, Lisa Kirchhoff, Dirk Schmidt, Jan Buer, Joerg Steinmann, Peter‐Michael Rath   +5 more
wiley   +1 more source

A Rare Case of Splenic Pneumocystis jirovecii in a HIV‐Positive Patient

Case Reports in Gastrointestinal Medicine, Volume 2020, Issue 1, 2020., 2020
Introduction. Human immunodeficiency virus (HIV) positive individuals with the CD4 count less than 200 cells/mm3 are at risk for opportunistic infections. Pneumocystis jirovecii, a fungal pathogen, is a common cause of opportunistic infections with predominantly pulmonary involvement. Disseminated P.
Hafsa Abbas, Harish Patel, Ahmed Baiomi, Masooma Niazi, Trupti Vakde, Sridhar Chilimuri, Yoshihiro Moriwaki   +6 more
wiley   +1 more source

Functional characterization of Pneumocystis carinii brl1 by transspecies complementation analysis [PDF]

, 2007
Pneumocystis jirovecii is a fungus which causes severe opportunistic infections in immunocompromised humans. The brl1 gene of P. carinii infecting rats was identified and characterized by using bioinformatics in conjunction with functional ...
Cerutti, L., Hauser, P. M., Viesturs Simanis, Simanis, V., Cockell, M., Libera Lo Presti, Moira Cockell, Presti, L. L., Hauser, P. M., Simanis, V., Lo Presti, L., Lorenzo Cerutti, Cockell, M., Philippe M. Hauser, Cerutti, L.   +14 more
core   +1 more source